Sunpharma has been trading in a channel since March 2020. It's now at its lower trendline and has broken trendline 1 as well. This generates an opportunity to go long!
The stock is also supported by 50 day EMA which further strengthens the conviction.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.